$TEVA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in TEVA PHARMACEUTICAL INDUSTRIES LTD. Get notifications about new insider transactions in TEVA PHARMACEUTICAL INDUSTRIES LTD for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | Satchi-Fainaro Ronit | Director | Option Exercise | M | 0.00 | 17,621 | 0 | 0 | |
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | Satchi-Fainaro Ronit | Director | Buy | M | 0.00 | 17,621 | 0 | 17,621 | 0 to 17.6 K |
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | Peres Nechemia Jacob | Director | Option Exercise | M | 0.00 | 17,621 | 0 | 0 | |
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | Peres Nechemia Jacob | Director | Buy | M | 0.00 | 17,621 | 0 | 17,621 | 0 to 17.6 K |
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | Nisen Perry | Director | Option Exercise | M | 0.00 | 17,621 | 0 | 0 | |
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | Nisen Perry | Director | Buy | M | 0.00 | 17,621 | 0 | 17,621 | 0 to 17.6 K |
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | MIGNONE ROBERTO | Director | Option Exercise | M | 0.00 | 17,621 | 0 | 0 | |
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | MIGNONE ROBERTO | Director | Buy | M | 0.00 | 17,621 | 0 | 17,621 | 0 to 17.6 K |
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | LIEBERMAN GERALD M | Director | Option Exercise | M | 0.00 | 17,621 | 0 | 0 | |
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | LIEBERMAN GERALD M | Director | Buy | M | 0.00 | 17,621 | 0 | 27,963 | 10.3 K to 28 K (+170.38 %) |
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | Halfon Jean Michel | Director | Option Exercise | M | 0.00 | 17,621 | 0 | 0 | |
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | Halfon Jean Michel | Director | Buy | M | 0.00 | 17,621 | 0 | 22,563 | 4.9 K to 22.6 K (+356.56 %) |
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | Elstein Amir | Director | Option Exercise | M | 0.00 | 17,621 | 0 | 0 | |
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | Elstein Amir | Director | Buy | M | 0.00 | 17,621 | 0 | 2,016,269 | 2 M to 2 M (+0.88 %) |
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | Crane Rosemary A | Director | Option Exercise | M | 0.00 | 17,621 | 0 | 0 | |
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | Crane Rosemary A | Director | Buy | M | 0.00 | 17,621 | 0 | 28,413 | 10.8 K to 28.4 K (+163.28 %) |
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Option Exercise | M | 0.00 | 31,388 | 0 | 0 | |
Jun 15 2020 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Buy | M | 0.00 | 31,388 | 0 | 254,300 | 222.9 K to 254.3 K (+14.08 %) |
Jun 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Vergis Janet S. | Director | Option Exercise | A | 0.00 | 12,668 | 0 | 12,668 | |
Jun 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Satchi-Fainaro Ronit | Director | Option Exercise | A | 0.00 | 12,668 | 0 | 12,668 | |
Jun 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Peres Nechemia Jacob | Director | Option Exercise | A | 0.00 | 12,668 | 0 | 12,668 | |
Jun 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Nisen Perry | Director | Option Exercise | A | 0.00 | 12,668 | 0 | 12,668 | |
Jun 11 2020 | TEVA | TEVA PHARMACEUTICA ... | MIGNONE ROBERTO | Director | Option Exercise | A | 0.00 | 12,668 | 0 | 12,668 | |
Jun 11 2020 | TEVA | TEVA PHARMACEUTICA ... | LIEBERMAN GERALD M | Director | Option Exercise | A | 0.00 | 12,668 | 0 | 12,668 | |
Jun 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Halfon Jean Michel | Director | Option Exercise | A | 0.00 | 12,668 | 0 | 12,668 | |
Jun 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Elstein Amir | Director | Option Exercise | A | 0.00 | 12,668 | 0 | 12,668 | |
Jun 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Crane Rosemary A | Director | Option Exercise | A | 0.00 | 12,668 | 0 | 12,668 | |
Jun 11 2020 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Option Exercise | A | 0.00 | 22,565 | 0 | 22,565 | |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Option Exercise | M | 0.00 | 944 | 0 | 0 | |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Sell | S | 7.16 | 944 | 6,762 | 0 | 944 to 0 (-100.00 %) |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Buy | M | 0.00 | 944 | 0 | 944 | 0 to 944 |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | M | 0.00 | 2,359 | 0 | 0 | |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Sell | S | 7.16 | 2,359 | 16,899 | 2,974 | 5.3 K to 3 K (-44.23 %) |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Buy | M | 0.00 | 2,359 | 0 | 5,333 | 3 K to 5.3 K (+79.32 %) |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Option Exercise | M | 0.00 | 1,179 | 0 | 0 | |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Sell | S | 7.16 | 470 | 3,367 | 14,868 | 15.3 K to 14.9 K (-3.06 %) |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Buy | M | 0.00 | 1,179 | 0 | 15,338 | 14.2 K to 15.3 K (+8.33 %) |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Option Exercise | M | 0.00 | 874 | 0 | 0 | |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Sell | S | 7.17 | 345 | 2,474 | 19,844 | 20.2 K to 19.8 K (-1.71 %) |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Buy | M | 0.00 | 874 | 0 | 20,189 | 19.3 K to 20.2 K (+4.52 %) |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 266 | 0 | 0 | |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 748 | 0 | 0 | |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 7.16 | 134 | 960 | 45,561 | 45.7 K to 45.6 K (-0.29 %) |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 7.16 | 380 | 2,722 | 45,695 | 46.1 K to 45.7 K (-0.82 %) |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 266 | 0 | 46,075 | 45.8 K to 46.1 K (+0.58 %) |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 748 | 0 | 45,809 | 45.1 K to 45.8 K (+1.66 %) |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | M | 0.00 | 1,179 | 0 | 0 | |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Buy | M | 0.00 | 1,179 | 0 | 20,639 | 19.5 K to 20.6 K (+6.06 %) |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | M | 0.00 | 1,297 | 0 | 0 | |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Sell | S | 7.17 | 616 | 4,418 | 10,400 | 11 K to 10.4 K (-5.59 %) |
Mar 19 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Buy | M | 0.00 | 1,297 | 0 | 11,016 | 9.7 K to 11 K (+13.34 %) |
Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Option Exercise | M | 0.00 | 4,807 | 0 | 14,424 | |
Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Sell | S | 11.23 | 4,807 | 53,980 | 0 | 4.8 K to 0 (-100.00 %) |
Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Buy | M | 0.00 | 4,807 | 0 | 4,807 | 0 to 4.8 K |
Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Option Exercise | M | 0.00 | 1,166 | 0 | 1,166 | |
Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Sell | S | 11.37 | 463 | 5,262 | 14,159 | 14.6 K to 14.2 K (-3.17 %) |
Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Buy | M | 0.00 | 1,166 | 0 | 14,622 | 13.5 K to 14.6 K (+8.67 %) |
Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Option Exercise | M | 0.00 | 1,399 | 0 | 1,400 | |
Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Sell | S | 11.77 | 548 | 6,448 | 19,315 | 19.9 K to 19.3 K (-2.76 %) |
Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Buy | M | 0.00 | 1,399 | 0 | 19,863 | 18.5 K to 19.9 K (+7.58 %) |
Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | M | 0.00 | 1,399 | 0 | 1,400 | |
Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Buy | M | 0.00 | 1,399 | 0 | 19,460 | 18.1 K to 19.5 K (+7.75 %) |
Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | M | 0.00 | 2,098 | 0 | 2,101 | |
Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Sell | S | 11.77 | 991 | 11,660 | 9,719 | 10.7 K to 9.7 K (-9.25 %) |
Mar 05 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Buy | M | 0.00 | 2,098 | 0 | 10,710 | 8.6 K to 10.7 K (+24.36 %) |
Mar 04 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Option Exercise | M | 0.00 | 1,166 | 0 | 1,166 | |
Mar 04 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Option Exercise | M | 0.00 | 2,941 | 0 | 5,882 | |
Mar 04 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Sell | S | 11.37 | 1,166 | 13,253 | 0 | 1.2 K to 0 (-100.00 %) |
Mar 04 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Buy | M | 0.00 | 1,166 | 0 | 1,166 | 0 to 1.2 K |
Mar 04 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Sell | S | 11.60 | 2,941 | 34,112 | 0 | 2.9 K to 0 (-100.00 %) |
Mar 04 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Buy | M | 0.00 | 2,941 | 0 | 2,941 | 0 to 2.9 K |
Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | A | 0.00 | 73,720 | 0 | 73,720 | |
Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Schultz Kare | President and CEO | Option Exercise | A | 0.00 | 260,190 | 0 | 260,190 | |
Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Option Exercise | A | 0.00 | 82,393 | 0 | 82,393 | |
Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Option Exercise | A | 0.00 | 99,739 | 0 | 99,739 | |
Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, International ... | Option Exercise | A | 0.00 | 60,711 | 0 | 60,711 | |
Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Kalif Eliyahu Sharon | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 73,720 | 0 | 73,720 | |
Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Griffin Deborah A | Chief Accounting Of ... | Option Exercise | A | 0.00 | 21,459 | 0 | 21,459 | |
Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | A | 0.00 | 86,730 | 0 | 86,730 | |
Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Option Exercise | A | 0.00 | 78,057 | 0 | 78,057 | |
Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | A | 0.00 | 69,384 | 0 | 69,384 | |
Mar 03 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | A | 0.00 | 82,393 | 0 | 82,393 | |
Feb 20 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Sell | S | 12.51 | 8,000 | 100,080 | 21,494 | 29.5 K to 21.5 K (-27.12 %) |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | M | 0.00 | 3,926 | 0 | 3,926 | |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | M | 0.00 | 13,090 | 0 | 0 | |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Sell | S | 12.14 | 3,926 | 47,670 | 2,974 | 6.9 K to 3 K (-56.90 %) |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Sell | S | 12.14 | 13,090 | 158,941 | 6,900 | 20 K to 6.9 K (-65.48 %) |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Buy | M | 0.00 | 3,926 | 0 | 19,990 | 16.1 K to 20 K (+24.44 %) |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Buy | M | 0.00 | 13,090 | 0 | 16,064 | 3 K to 16.1 K (+440.15 %) |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Option Exercise | M | 0.00 | 19,040 | 0 | 0 | |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Option Exercise | M | 0.00 | 5,710 | 0 | 5,712 | |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Buy | M | 0.00 | 5,710 | 0 | 24,750 | 19 K to 24.8 K (+29.99 %) |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Buy | M | 0.00 | 19,040 | 0 | 19,040 | 0 to 19 K |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Sell | S | 13.03 | 72,131 | 939,766 | 0 | 72.1 K to 0 (-100.00 %) |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 17,850 | 0 | 0 | |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 5,353 | 0 | 5,355 | |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 12.14 | 8,825 | 107,155 | 45,061 | 53.9 K to 45.1 K (-16.38 %) |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 12.14 | 2,647 | 32,140 | 53,886 | 56.5 K to 53.9 K (-4.68 %) |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 17,850 | 0 | 56,533 | 38.7 K to 56.5 K (+46.14 %) |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 5,353 | 0 | 38,683 | 33.3 K to 38.7 K (+16.06 %) |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Option Exercise | M | 0.00 | 3,926 | 0 | 3,926 | |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Option Exercise | M | 0.00 | 13,090 | 0 | 0 | |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Sell | S | 12.14 | 1,878 | 22,791 | 29,494 | 31.4 K to 29.5 K (-5.99 %) |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Sell | S | 12.14 | 6,262 | 75,994 | 31,372 | 37.6 K to 31.4 K (-16.64 %) |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Buy | M | 0.00 | 3,926 | 0 | 37,634 | 33.7 K to 37.6 K (+11.65 %) |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Buy | M | 0.00 | 13,090 | 0 | 33,708 | 20.6 K to 33.7 K (+63.49 %) |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | Kalif Eliyahu Sharon | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 19,888 | 0 | 19,888 | |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Option Exercise | M | 0.00 | 2,470 | 0 | 0 | |
Feb 18 2020 | TEVA | TEVA PHARMACEUTICA ... | BARER SOL J | Director | Buy | M | 0.00 | 2,470 | 0 | 222,912 | 220.4 K to 222.9 K (+1.12 %) |
Feb 13 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | A | 0.00 | 13,090 | 0 | 13,090 | |
Feb 13 2020 | TEVA | TEVA PHARMACEUTICA ... | Schultz Kare | President and CEO | Option Exercise | A | 0.00 | 212,314 | 0 | 212,314 | |
Feb 13 2020 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Option Exercise | A | 0.00 | 19,040 | 0 | 19,040 | |
Feb 13 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | A | 0.00 | 17,850 | 0 | 17,850 | |
Feb 13 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Option Exercise | A | 0.00 | 13,090 | 0 | 13,090 | |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Option Exercise | M | 0.00 | 12,538 | 0 | 25,076 | |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Sell | S | 12.24 | 12,538 | 153,471 | 2,974 | 15.5 K to 3 K (-80.83 %) |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Stark David Matthew | Exec. VP Chief Lega ... | Buy | M | 0.00 | 12,538 | 0 | 15,512 | 3 K to 15.5 K (+421.59 %) |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Schultz Kare | President and CEO | Option Exercise | M | 0.00 | 26,867 | 0 | 53,734 | |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Schultz Kare | President and CEO | Buy | M | 0.00 | 26,867 | 0 | 90,480 | 63.6 K to 90.5 K (+42.24 %) |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Option Exercise | M | 0.00 | 15,523 | 0 | 31,046 | |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Sabag Mark | See "Remarks" below | Buy | M | 0.00 | 15,523 | 0 | 72,131 | 56.6 K to 72.1 K (+27.42 %) |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Option Exercise | M | 0.00 | 16,120 | 0 | 32,241 | |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Sell | S | 12.27 | 4,799 | 58,884 | 13,456 | 18.3 K to 13.5 K (-26.29 %) |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | O'Grady Brendan P. | EVP, North America ... | Buy | M | 0.00 | 16,120 | 0 | 18,255 | 2.1 K to 18.3 K (+755.04 %) |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, Growth Markets ... | Option Exercise | M | 0.00 | 11,941 | 0 | 23,882 | |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, Growth Markets ... | Sell | S | 12.24 | 4,155 | 50,864 | 18,464 | 22.6 K to 18.5 K (-18.37 %) |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Nazzi Gianfranco | EVP, Growth Markets ... | Buy | M | 0.00 | 11,941 | 0 | 22,619 | 10.7 K to 22.6 K (+111.83 %) |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 16,120 | 0 | 32,241 | |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 12.27 | 5,544 | 68,025 | 33,330 | 38.9 K to 33.3 K (-14.26 %) |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 16,120 | 0 | 38,874 | 22.8 K to 38.9 K (+70.84 %) |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Option Exercise | M | 0.00 | 6,567 | 0 | 13,135 | |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Sell | S | 12.24 | 3,144 | 38,488 | 20,618 | 23.8 K to 20.6 K (-13.23 %) |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Drape Eric | Executive VP Global ... | Buy | M | 0.00 | 6,567 | 0 | 23,762 | 17.2 K to 23.8 K (+38.19 %) |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Option Exercise | M | 0.00 | 13,135 | 0 | 26,270 | |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Sell | S | 12.27 | 5,669 | 69,559 | 18,061 | 23.7 K to 18.1 K (-23.89 %) |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Dethlefs Sven | EVP Global Marketin ... | Buy | M | 0.00 | 13,135 | 0 | 23,730 | 10.6 K to 23.7 K (+123.97 %) |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Option Exercise | M | 0.00 | 13,135 | 0 | 26,270 | |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Sell | S | 12.24 | 6,199 | 75,886 | 8,612 | 14.8 K to 8.6 K (-41.85 %) |
Feb 11 2020 | TEVA | TEVA PHARMACEUTICA ... | Daniell Richard | Exec. VP, European ... | Buy | M | 0.00 | 13,135 | 0 | 14,811 | 1.7 K to 14.8 K (+783.71 %) |
Jan 02 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 4,640 | 0 | 0 | |
Jan 02 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 9.92 | 2,459 | 24,396 | 22,754 | 25.2 K to 22.8 K (-9.75 %) |
Jan 02 2020 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 4,640 | 0 | 25,213 | 20.6 K to 25.2 K (+22.55 %) |
Dec 03 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Option Exercise | M | 0.00 | 8,133 | 0 | 0 | |
Dec 03 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Sell | S | 10.49 | 4,310 | 45,214 | 20,573 | 24.9 K to 20.6 K (-17.32 %) |
Dec 03 2019 | TEVA | TEVA PHARMACEUTICA ... | Fridriksdottir Hafrun | Executive VP, Globa ... | Buy | M | 0.00 | 8,133 | 0 | 24,883 | 16.8 K to 24.9 K (+48.56 %) |
Nov 06 2019 | TEVA | TEVA PHARMACEUTICA ... | McClellan Michael James | EVP, Chief Financia ... | Option Exercise | M | 0.00 | 695 | 0 | 0 | |
Nov 06 2019 | TEVA | TEVA PHARMACEUTICA ... | McClellan Michael James | EVP, Chief Financia ... | Sell | S | 8.83 | 242 | 2,138 | 15,898 | 16.1 K to 15.9 K (-1.50 %) |
Nov 06 2019 | TEVA | TEVA PHARMACEUTICA ... | McClellan Michael James | EVP, Chief Financia ... | Buy | M | 0.00 | 695 | 0 | 16,140 | 15.4 K to 16.1 K (+4.50 %) |
Nov 05 2019 | TEVA | TEVA PHARMACEUTICA ... | Schultz Kare | President and CEO | Option Exercise | M | 0.00 | 63,613 | 0 | 476,389 | |
Nov 05 2019 | TEVA | TEVA PHARMACEUTICA ... | Schultz Kare | President and CEO | Buy | M | 0.00 | 63,613 | 0 | 63,613 | 0 to 63.6 K |